GLI1 and cancer: These findings are in agreement with other reports proving the inhibitory activity of RV on the Hedgehog-GLI pathway in different cancers, supporting its adjuvant therapeutic potential to treat cancers with hyper-active Hedgehog signaling [52,53,54,55,56,57].